152 related articles for article (PubMed ID: 8692311)
1. [Extensive lymph node dissection in stomach cancer? Initial results of the Dutch Stomach Cancer Study].
Bonenkamp JJ; Songun I; Hermans J; van de Velde CJ
Ned Tijdschr Geneeskd; 1996 May; 140(18):964-7. PubMed ID: 8692311
[TBL] [Abstract][Full Text] [Related]
2. Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial.
Degiuli M; Sasako M; Calgaro M; Garino M; Rebecchi F; Mineccia M; Scaglione D; Andreone D; Ponti A; Calvo F;
Eur J Surg Oncol; 2004 Apr; 30(3):303-8. PubMed ID: 15028313
[TBL] [Abstract][Full Text] [Related]
3. R2 compared with R1 resection for gastric cancer: morbidity and mortality in a prospective, randomised trial.
Bonenkamp JJ; van de Velde CJ; Sasako M; Hermans J
Eur J Surg; 1992 Aug; 158(8):413-8. PubMed ID: 1356480
[TBL] [Abstract][Full Text] [Related]
4. Resection for gastric cancer in the community.
van de Velde CJ
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441
[TBL] [Abstract][Full Text] [Related]
5. Gastric carcinoma: does lymph node dissection alter survival?
Wanebo HJ; Kennedy BJ; Winchester DP; Fremgen A; Stewart AK
J Am Coll Surg; 1996 Dec; 183(6):616-24. PubMed ID: 8957465
[TBL] [Abstract][Full Text] [Related]
6. [D3 versus D2 dissection in stomach carcinoma. A case-control study of postoperative morbidity, survival and early oncologic outcome].
Bittorf BR; Günther F; Merkel S; Horbach T; Hohenberger W; Günther K
Chirurg; 2002 Apr; 73(4):336-47. PubMed ID: 12063918
[TBL] [Abstract][Full Text] [Related]
7. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial.
Hartgrink HH; van de Velde CJ; Putter H; Bonenkamp JJ; Klein Kranenbarg E; Songun I; Welvaart K; van Krieken JH; Meijer S; Plukker JT; van Elk PJ; Obertop H; Gouma DJ; van Lanschot JJ; Taat CW; de Graaf PW; von Meyenfeldt MF; Tilanus H; Sasako M
J Clin Oncol; 2004 Jun; 22(11):2069-77. PubMed ID: 15082726
[TBL] [Abstract][Full Text] [Related]
8. Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: a prospective long-term follow-up study.
Roukos DH; Lorenz M; Encke A
Surgery; 1998 May; 123(5):573-8. PubMed ID: 9591011
[TBL] [Abstract][Full Text] [Related]
9. Extended lymph-node dissection for gastric cancer.
Bonenkamp JJ; Hermans J; Sasako M; van de Velde CJ; Welvaart K; Songun I; Meyer S; Plukker JT; Van Elk P; Obertop H; Gouma DJ; van Lanschot JJ; Taat CW; de Graaf PW; von Meyenfeldt MF; Tilanus H;
N Engl J Med; 1999 Mar; 340(12):908-14. PubMed ID: 10089184
[TBL] [Abstract][Full Text] [Related]
10. Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection?
Ramacciato G; Aurello P; D'Angelo F; Cicchini C; Sternberg CN
Hepatogastroenterology; 2000; 47(35):1470-4. PubMed ID: 11100379
[TBL] [Abstract][Full Text] [Related]
11. The effectiveness of extended lymph node dissection for gastric cancer performed in Costa Rica under the supervision of a Japanese surgeon: a comparison with surgical results in Japan.
Sasagawa T; Solano H; Vega W; Mena F
Am J Surg; 2008 Jan; 195(1):53-60. PubMed ID: 18082543
[TBL] [Abstract][Full Text] [Related]
12. Comparison of surgical results of D2 versus D3 gastrectomy (para-aortic lymph node dissection) for advanced gastric carcinoma: a multi-institutional study.
Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono H; Nagahori Y; Hosoi H; Takahashi M; Kito F; Shimada H
Ann Surg Oncol; 2006 May; 13(5):659-67. PubMed ID: 16538414
[TBL] [Abstract][Full Text] [Related]
13. Prognostic importance of radical lymphadenectomy in curative resections for gastric cancer.
Viste A; Svanes K; Janssen CW; Maartmann-Moe H; Søreide O
Eur J Surg; 1994 Sep; 160(9):497-502. PubMed ID: 7849169
[TBL] [Abstract][Full Text] [Related]
14. Indications for pancreaticosplenectomy in advanced gastric cancer.
Chikara K; Hiroshi S; Masato N; Hirotoshi A; Goro M; Hidetaka O
Hepatogastroenterology; 2001; 48(39):908-12. PubMed ID: 11462954
[TBL] [Abstract][Full Text] [Related]
15. Postoperative morbidity and mortality after gastrectomy for gastric carcinoma.
Ikeguchi M; Oka S; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
Hepatogastroenterology; 2001; 48(41):1517-20. PubMed ID: 11677999
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of radical D2-lymphadenectomy and splenectomy in surgically treated gastric cancer patients.
Schmid A; Thybusch A; Kremer B; Henne-Bruns D
Hepatogastroenterology; 2000; 47(32):579-85. PubMed ID: 10791243
[TBL] [Abstract][Full Text] [Related]
17. Extended lymph-node dissection for gastric cancer: a challenge for better survival results.
Plukker JT; Kampschöer GH
Neth J Surg; 1990 Feb; 42(1):3-8. PubMed ID: 2320276
[TBL] [Abstract][Full Text] [Related]
18. A phase-II clinical trial of laparoscopy-assisted distal gastrectomy with D2 lymph node dissection for gastric cancer patients.
Lee JH; Kim YW; Ryu KW; Lee JR; Kim CG; Choi IJ; Kook MC; Nam BH; Bae JM
Ann Surg Oncol; 2007 Nov; 14(11):3148-53. PubMed ID: 17705092
[TBL] [Abstract][Full Text] [Related]
19. [The role of superextended lymphadenectomy (D4) in gastric cancer].
Pugliese R; Maggioni D; Sansonna F; Scandroglio I; Di Lernia S; Boniardi M; Bramerio MA
Minerva Chir; 2004 Aug; 59(4):325-35. PubMed ID: 15278027
[TBL] [Abstract][Full Text] [Related]
20. [Comparative study of D1 and D2 ganglionic dissection in advanced gastric cancer at Rebagliati Hospital].
Cornejo C; Portanova M
Rev Gastroenterol Peru; 2006; 26(4):351-6. PubMed ID: 17211484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
